Medicare payment changes to boost access to innovative nuclear diagnostics.
This law changes Medicare payment rules to ensure hospitals receive separate reimbursement for expensive, innovative drugs used in nuclear diagnostics (radiopharmaceuticals). The goal is to guarantee that Medicare beneficiaries have easier access to the latest disease detection methods. These changes take effect on January 1, 2024.
Key points
Medicare will pay hospitals separately for expensive diagnostic drugs (radiopharmaceuticals) if their cost exceeds $500 per day (this threshold will increase annually).
This change removes a financial barrier for hospitals, aiming to improve Medicare beneficiaries' access to modern and innovative diagnostic tests.
The new payment rules will not affect the amount of out-of-pocket costs (copayments) paid by patients.
Expired
Citizen Poll